FRANKLIN, Tenn., June 13, 2024 -- Azra AI, a healthtech leader harnessing artificial intelligence (AI) and workflow automation to accelerate the identification and treatment of cancer, is pleased to announce the addition of two new board members, strengthening the company's capabilities to meet the growing market demand and drive innovation in healthcare solutions.
Isaac Ullatil and Michele Chulick have joined Azra AI's Board of Directors, bringing a wealth of experience and strategic vision to the company's leadership.
Isaac Ullatil is an accomplished executive with extensive experience in healthcare technology and strategic business development. As the co-founder and former CEO of Hallmark Health Care Solutions (HHCS), Isaac has led initiatives that saved clients hundreds of millions of dollars in labor and operational costs. Recognized by The Healthcare Technology Report as one of the Top 50 Healthcare Technology CEOs in 2022, he has a strong track record of developing high-end technology solutions and reengineering business processes to optimize operations. Isaac's strategic insights and leadership will guide Azra AI in navigating the complexities of the healthcare landscape and achieving sustained growth.
Michele Chulick brings over 30 years of leadership experience in the healthcare sector, including her tenure as President and CEO of Wyoming Medical Center (WMC). Under her leadership, WMC expanded its telehealth network and completed a significant affiliation with Banner Health, enhancing the hospital's capabilities and financial foundation. Michele's expertise in strategic planning, value-based care management, and healthcare operations will be instrumental in shaping Azra AI's strategic direction and ensuring alignment with customer needs.
"We are thrilled to welcome Isaac and Michele to the Azra AI team. Their combined expertise and leadership will be pivotal as we continue to innovate and deliver compelling solutions that meet the specific needs of healthcare providers. With their support, we are well-positioned to seize the momentum in the growing market and drive our mission forward,” said John Marshall, CEO of Azra AI.
Azra AI's expansion of its leadership team comes at a crucial time as the company experiences increasing demand for its AI-powered oncology workflow automation solutions. By enhancing its leadership with experienced professionals, Azra AI aims to accelerate innovation, improve healthcare provider satisfaction, and achieve its goal of transforming oncology care through intelligent automation.
Additional Resources
- Watch Azra AI’s full webinar titled “Harnessing AI for Oncology Service Line Excellence” moderated by Brook Blackmore, RN, MSN, MBA with guest panelists Dr. Douglas Flora from St. Elizabeth Healthcare and Jami DeNigris from Inspira Health.
- Schedule a demo with our experts at www.azra-ai.com/get-a-demo.
- Stay at the forefront of healthtech innovation and insights by following Azra AI on LinkedIn for exciting updates and thought-provoking content.
About Azra AI
Azra AI is a healthtech firm that leverages advanced AI and machine learning to automate oncology workflows. Its proven SaaS enterprise platform is used by more than 200 hospitals and cancer centers across the country to identify positive cancer diagnoses and incidental findings in real-time, classify by primary site, and route those patients to cancer navigators and other staff to immediately start the cancer care journey. The results include faster time to treatment, increased navigator time with patients, and better oncology patient retention. Additionally, the solution delivers dramatic operational and financial gains through intelligent automation.
